TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling
Article in Cells (March 2024)
TRAIL, Fas Ligand, TNF and TLR3 in Cancer
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Resistance to TRAIL Pathway-Targeted Therapeutics in Cancer
-
Altmetric BadgeChapter 2 TRAIL-R3/R4 and Inhibition of TRAIL Signalling in Cancer
-
Altmetric BadgeChapter 3 IAPs and Resistance to Death Receptors in Cancer
-
Altmetric BadgeChapter 4 Bcl-2 Proteins and TRAIL Resistance in Melanoma
-
Altmetric BadgeChapter 5 Regulation of Caspase-Mediated Apoptosis by the Tumor Suppressor Par-4
-
Altmetric BadgeChapter 6 Stem Cell Regulation by Death Ligands and Their Use in Cell Therapy
-
Altmetric BadgeChapter 7 Atypical Immune Functions of CD95/CD95L
-
Altmetric BadgeChapter 8 TLR3 Is a Death Receptor Target in Cancer Therapy
-
Altmetric BadgeChapter 9 Fas/CD95, Lipid Rafts, and Cancer
-
Altmetric BadgeChapter 10 Role of Sphingolipids in Death Receptor Signalling
-
Altmetric BadgeChapter 11 Posttranslational Modifications and Death Receptor Signalling
-
Altmetric BadgeChapter 12 System Modeling of Receptor-Induced Apoptosis